Cardiac safety testing is a critical element in assuring the health and safety of clinical trial participants – whether the trial is being conducted in-clinic or at-home. In an at-home setting, having the ability to capture ECGs, transfer data and provide analyses comparable to trials conducted in-clinic, is paramount.

In this webinar, attendees will learn how BioTel Research, now part of Philips, is leveraging the 12-lead, at-home, ECG device to provide an integrated, remote monitoring solution designed with the patient in mind while meeting the requirements and flexibility needed by sponsors.

Keywords:

Speakers

Sandhya Seshadri, Product Manager, Philips BioTel Research

Sandhya Seshadri (Sandy) is a Product Manager for BioTel Research, now a part of Philips, and she brings 16+ years experience in IT software development; with a specialty in clinical trials imaging platforms and SaaS-based solutions. She has held numerous software development positions on various innovative solutions, and she is currently pursuing a Masters in Management degree. She has a Bachelors in Computer Science and Engineering.

Message Presenter

Dr. Ruey-Kang Chang, CEO, QT Medical

Dr. Ruey-Kang Chang is a Pediatric Cardiologist, Professor of Pediatrics at The University of California, Los Angeles (UCLA), and Founder & CEO of QT Medical. In his academic career, Dr. Chang utilized a public health approach to solve important clinical problems such as the prevention of deaths from silent or undiagnosed heart conditions. He is now using his innovative technology and business model to achieve this goal on a much larger scale. He founded QT Medical to reinvent the medical-grade electrocardiogram (ECG) and make this valuable test of the heart readily available to millions of patients at home. This ECG system, called PCA 500, is the perfect ECG solution for decentralized and hybrid clinical trials.

Message Presenter

Who Should Attend?

This webinar will benefit those involved in clinical trials from pharma, biotech, and CROs backgrounds; especially those who focus in cardiac safety testing or are looking for more information on the expansion of decentralized clinical trials.

Clinical researchers
Clinical development
Clinical operations
Project management
Procurement leads
Cardiac scientific/medical leads

What You Will Learn

Attendees will learn:

Why cardiac safety testing is critical for clinical trial patients
Why at-home data collection and analyses must be comparable to in-clinic testing
How BioTel Research is developing innovative approaches to cardiac safety testing

Xtalks Partner

Philips BioTel Research

Philips BioTel Research is an industry leader in medical imaging and cardiovascular safety testing for clinical trials. Philips BioTel Research offers global operational support for cardiovascular monitoring in all therapeutic areas, and advanced imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic, and medical device studies. Their experienced research team comprises key opinion leaders, board-certified cardiologists and radiologists, sub-specialty scientists, and highly trained technicians — who acquire, evaluate, and report high-quality data through an efficient, cloud-based infrastructure. Many biopharmaceutical trial sponsors rely on our scientific leaders to help design and optimize their protocols and statistical analysis plans. We have conducted clinical trials contributing to the market approval of nearly 100 new drugs to date.